Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
25.04. | Polarean Imaging PLC - Notice of Results | - | RNS | ||
10.03. | Polarean Imaging PLC - Expansion of Xenon MRI imaging platform | 1 | RNS | ||
27.02. | Polarean Imaging PLC - FY24 trading update | - | RNS | ||
19.02. | Polarean Imaging PLC - Virtual Investor Day | - | RNS | ||
03.02. | Polarean Imaging shares jump as inks first distribution deal in Taiwan | - | Alliance News | ||
03.02. | Polarean Imaging PLC - Taiwanese distributor agreement with Sumtage | - | RNS | ||
30.01. | Polarean Imaging PLC - Key patent in China secured | - | RNS | ||
28.01. | Polarean Imaging PLC - Collaboration to Advance Lung Imaging Innovation | - | RNS | ||
21.11.24 | IN BRIEF: Polarean Imaging gets FDA approval for MRI chest coil | 4 | Alliance News | ||
21.11.24 | Polarean's Xenoview 3T gets new FDA clearance | 1 | Sharecast | ||
21.11.24 | Polarean: FDA clears XENOVIEW 3T Chest Coil in GE HealthCare MRI Systems | 5 | GlobeNewswire (USA) | ||
21.11.24 | Polarean Imaging PLC - FDA clears Chest Coil in GE HealthCare MRI Systems | 2 | RNS | ||
28.08.24 | Polarean Imaging plc: Appointment of Chase Hall, M.D., as Chief Medical Advisor | 309 | GlobeNewswire (Europe) | DURHAM, NC and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces... ► Artikel lesen | |
23.05.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 23.05.2024 | 895 | Xetra Newsboard | Das Instrument 49S GB00B60BD277 SUPERDRY PLC LS -,01 EQUITY wird ex Kapitalmassnahme gehandelt am 23.05.2024 The instrument 49S GB00B60BD277 SUPERDRY PLC LS -,01 EQUITY is traded ex capital adjustment... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDTRONIC | 73,75 | -1,71 % | Medtronic Education Program Opens Doors for Employees | Illness in the family sparked Christopher Hibbler's interest in medicine. Our MAPS program is helping make his dream come true NORTHAMPTON, MA / ACCESS Newswire / April 30, 2025 / No one knew it at... ► Artikel lesen | |
HCA HEALTHCARE | 305,20 | -0,88 % | HCA Healthcare, Inc. - 10-Q, Quarterly Report | ||
LANTHEUS | 94,80 | -1,39 % | Lantheus Holdings, Inc.: Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies | BEDFORD, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight... ► Artikel lesen | |
AMEDISYS | 84,00 | +1,20 % | UnitedHealth, Amedisys find buyers for divestitures as they seek to close $3.3B merger | ||
ENVISTA | 14,800 | -1,99 % | Envista Holdings Corporation: Envista Reports First Quarter 2025 Results | BREA, Calif., May 1, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended March 28, 2025.
"In the first... ► Artikel lesen | |
CAREDX | 13,015 | -1,48 % | Analyst Expectations For CareDx's Future | ||
SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fiscal Second Quarter 2025 Results | Reports 23 Percent Increase in ARR to $19.1 Million and 61 Net New Platform Deployments HENDERSON, Nev., Feb. 13, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading... ► Artikel lesen | |
GT BIOPHARMA | 2,280 | -15,56 % | GT Biopharma, Inc. - 8-K, Current Report | ||
CARMAT | 0,814 | -0,49 % | CARMAT: Availability of the 2024 Universal Registration Document | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen | |
CHEMOMETEC | 65,05 | -0,61 % | Chemometec A/S: Interim report 2024/25 - Solid H1 performance driven by growth in both revenue and earnings | ANNOUNCEMENT NO. 2875 February 2025 Solid H1 performance driven by growth in both revenue and earnings Martin Helbo Behrens, CEO: The growth continued in the second quarter of 2024/25, and revenue... ► Artikel lesen | |
HAMILTON THORNE | 1,490 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.12.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 02.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.12.2024ISIN NameCA81012R1064 SCOTTIE... ► Artikel lesen | |
DEVYSER DIAGNOSTICS | 9,740 | +3,07 % | Devyser Diagnostics AB: Devyser Diagnostics AB publishes quarterly report for the period January to March 2025 | "A quarter has passed since I took over as acting CEO and it has been an eventful first few months. Despite the turbulent environment, marked by geopolitical uncertainty, we are able to report our second... ► Artikel lesen | |
ARRAIL GROUP | 0,200 | +4,71 % | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | ||
PROMIMIC | 2,320 | +4,04 % | Karolinska Development AB (publ): Karolinska Developments portfolio company Promimic publishes positive results on reduction of bacteria growth on HAnano Surface | STOCKHOLM, SWEDEN, February 18 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic has published positive results showing a reduction of bacterial... ► Artikel lesen | |
FRESENIUS | 42,580 | +0,88 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Fresenius auf "Buy" mit einem Kursziel von 45 Euro belassen. Der Medizinkonzern dürfte erwartungsgemäß solide ins Jahr gestartet sein, schrieb... ► Artikel lesen |